Our excitement was stimulated when we discovered that serum CLU expression in advanced lung adenocarcinoma was significantly higher than that in early lung adenocarcinoma and healthy controls, and the overexpression trend was stable. The gene discussed is CLU; the disease is lung adenocarcinoma.